Printer Friendly

TARGETED GENETICS ELECTS JAMES D. GRANT TO BOARD OF DIRECTORS

 SEATTLE, Feb. 11 /PRNewswire/ -- Targeted Genetics Corp. (TGC) announced today the election of James D. Grant to its board of directors.
 Grant is chairman of the board of T Cell Sciences in Cambridge, Mass., and was also chief executive officer from 1986 to 1992. Previously he was vice president of CPC International Inc. from 1972-1986. He has also served as deputy commissioner of the U.S. Food and Drug Administration (FDA), and most recently was vice chairman of the Advisory Committee on the FDA, the "Edwards Committee" (1990-1991).
 "Jim Grant's tremendous expertise in matters related to the FDA and other regulatory agencies will be of great value to Targeted Genetics in the development of our gene therapies," said H. Stewart Parker, president and chief executive officer of Targeted Genetics.
 Grant also serves on the boards of Cangene Corp. and the Industrial Biotechnology Association.
 Targeted Genetics Corp. is a leader in the development of gene therapy treatments for acquired and inherited diseases. The company has begun its first Phase I trial, a gene therapy-based treatment for HIV infection.
 -0- 2/11/93
 /CONTACT: H. Stewart Parker of Targeted Genetics, 206-623-7612/


CO: Targeted Genetics Corp. ST: Washington IN: MTC SU: PER

SW-LM -- SE002 -- 5529 02/11/93 08:55 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Feb 11, 1993
Words:208
Previous Article:MAGMA POWER CO. REPORTS RECORD FOURTH QUARTER AND 1992 YEAR-END EARNINGS
Next Article:$340 MILLION IN FINANCING FOR BUSINESSES IN POLAND
Topics:


Related Articles
TARGETED GENETICS ELECTS O'NEILL DIRECTOR
TARGETED GENETICS ELECTS JEREMY CURNOCK COOK TO BOARD OF DIRECTORS
T CELL SCIENCES ANNOUNCES CHANGES IN MANAGEMENT
Targeted Genetics Elects Nelson L. Levy, Ph.d., M.D. to Board of Directors; Fills Board Seat Previously Held by Martin P. Sutter.
WMC Board of Directors Elects Seven New Members; M&I Corporation President Begins Term as Board Chair.
SEATTLE GENETICS AWARDED NIH FUNDED RESEARCH GRANT.
BIO Names Chairman, Board Members for 2005-2006.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters